Benefits:
Who can take the Guardant360 CDx blood test?
Individuals who have been diagnosed with advanced solid cancer (stage III/IV) whereby the cancer is not progressing on the current treatment or current tumour testing is incomplete or inconclusive.
Patient must have been off treatment for a minimum of 10 days.
Guardant360 CDx is not suitable for individuals with:
How does the process work?
How does the Guardant360 CDx test work?
Guardant360 CDx is a simple blood test which analyses 74 genes within your existing solid cancer tumour DNA, to provide cancer genomic alterations detected in your blood.
Some genomic alterations may mean you are more likely to respond to certain drugs, or, indicate your cancer could be resistant to treatment. An oncologist will interpret results to inform the best treatment for you.
The report will highlight current approved drugs available and drugs currently available on clinical trial.
Traditionally, the only way to analyse genomic changes in your cancer was through tissue biopsies. The Guardant360 CDx test can provide the same information from a simple blood draw.
How often should I test?
Testing frequency depends on your condition – the Oncologist will advise a test schedule that works best for you.
When will I get my results?
The results are typically returned to you via email within 7 working days of reaching the lab.
A member of our team will endeavour to respond as promptly as possible. To help us assist you efficiently, please ensure you’ve included your preferred contact details along with the nature of your enquiry.
We look forward to connecting with you soon.